Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04335175 · ClinicalTrials.gov registry record
Sensory Symptoms in Tourette Syndrome and Obsessive-Compulsive Disorder
A clinical trial of Obsessive - Compulsive Disorder and Tourette Syndrome, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT04335175: Completed study of Obsessive - Compulsive Disorder and Tourette Syndrome, sponsored by Vanderbilt University Medical Center.
NCT04335175 is a study of Obsessive - Compulsive Disorder and Tourette Syndrome that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 250 participants, below the 2,062-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04335175, a study of Obsessive - Compulsive Disorder and Tourette Syndrome, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to address two key questions related to sensory dysregulation in Tourette syndrome (TS) and obsessive compulsive disorder (OCD): 1) Is sensory dysregulation in OCD clinically distinct from that in TS? 2) To what extent does sensory dysregulation affect QOL in each of these disorders? Patients with TS, patients with OCD, and healthy controls will complete an online battery of validated questionnaires assessing sensory dysregulation, psychiatric symptoms, and quality of life.
Primary Outcome
36-item, validated self-report questionnaire assessing sensory gating symptoms, with score range 0-216. Higher scores indicate greater sensory gating impairment.
Conditions Studied
Interventions
- OTHER None - observational study
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2020-04-14 |
| Est. Completion | 2022-02-28 |
What the finished NCT04335175 record still lists
NCT04335175 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 2,062-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 1 intervention - of which None - observational study is the first listed.
NCT04335175 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT04335175 about?
NCT04335175 is a clinical study titled "Sensory Symptoms in Tourette Syndrome and Obsessive-Compulsive Disorder". This study seeks to address two key questions related to sensory dysregulation in Tourette syndrome (TS) and obsessive compulsive disorder (OCD): 1) Is sensory dysregulation in OCD clinically distinct from that in TS? 2) To what extent does sensory dysregulation affect QOL in each of these disorders...
What is the current status of trial NCT04335175?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2020-04-14. Estimated completion is 2022-02-28.
What conditions does trial NCT04335175 study?
This clinical trial studies the following conditions: Obsessive - Compulsive Disorder, Tourette Syndrome, Sensory Disorders.
What interventions are being tested in trial NCT04335175?
The interventions under investigation include: None - observational study (OTHER).
Who is sponsoring clinical trial NCT04335175?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04335175 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obsessive - Compulsive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04335175's enrollment target sits among peer trials
250 12th of 84 higher than 71 of 84 other Obsessive - Compulsive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obsessive - Compulsive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder
RECRUITING · NA
-
Mechanisms of Exposure Therapy for OCD
RECRUITING · NA
-
Using Personalized Assessments in the Treatment of Childhood OCD
RECRUITING · NA
-
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
RECRUITING · Phase 1
-
Neural Mechanisms of Response Inhibition Training for OCRD
RECRUITING · NA
-
MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI